Thiazolidinediones as anti-cancer agents. - Wikidata - awgldk - TriplyDB

Thiazolidinediones as anti-cancer agents.

Thiazolidinediones as anti-cancer agents.

http://www.wikidata.org/entity/Q37010188

about

The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease Effect of pioglitazone on survival and renal function in a mouse model of polycystic kidney disease Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth Synergistic interactions between heregulin and peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist in breast cancer cells.Emerging therapy for adrenocortical carcinoma.Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.Influence of cardiorespiratory fitness on PPARG mRNA expression using monozygotic twin case control Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study.Dietary modulation of inflammation-induced colorectal cancer through PPARγ.Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours.PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity.A PPAR-gamma agonist protects from radiation-induced intestinal toxicity.PPARγ agonist beyond glucose lowering effect.Diabetes-induced mechanophysiological changes in the small intestine and colon.Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.Differential modulation of farnesoid X receptor signaling pathway by the thiazolidinediones Unique Interactome Network Signatures for Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Modulation by Functional Selective Ligands.Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPARγ agonist treatment.Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators

P2860

Q27026813-34EEA93C-EA1D-446C-9C93-B2346299BC3E Q27302419-B35DC588-A3B9-485D-B0E4-E8782D008F1F Q28742454-603BA028-5B4E-4604-AD0A-0DD046326E40 Q33637525-D1177367-C41B-4472-A1BA-9679F26B0347 Q33688576-8145F2BA-64F5-4187-84BD-0BA9E9CAF860 Q33809071-42ACC128-F67D-4157-9EAB-FFAA8D06D535 Q33921641-5AC00EC8-0305-466A-8445-6FCC777320F4 Q34095570-E49904BC-2D58-4468-9C83-9363E59A0701 Q35011149-C4EE8107-1738-437E-9AE1-291E13298F5F Q35018399-16A2E5E7-F4A9-4F85-A904-4E7F7168529E Q35034870-7650A0ED-CFE3-4A53-964F-658A5FAD2F76 Q35051779-AC8E50E6-EB30-40DA-AC9F-EC2B5B9318F0 Q35297540-2CA3EFCE-ED39-4262-AA99-5BE249F0A2E7 Q35565610-4D24A050-DE59-451A-865C-9A92E39F3A11 Q36375151-1BC92098-173B-453E-9475-FA1DD9084DC3 Q36560240-8478CBEA-2BCF-4A7D-B986-C87BF2A155FC Q37166674-3B87224F-F9B3-4A9D-A99E-25CB4E330DDF Q37188588-2FB7B8E9-4D09-421F-AA24-2EE52BB613BC Q37641546-C357BC4E-33A7-4567-81A3-4C744765D474 Q37698546-754BB5AA-CD2D-4507-85DA-4CBF6DCA7E3F Q37857704-87637595-7673-402F-BD02-BCAA2134F006 Q39427195-0270E009-2F5D-47B2-9FBD-F83FE4575825 Q39514941-18E70F1F-CE0F-44D4-B205-78D1D080039D Q39860554-B63EED0F-65E4-45C7-90B9-CA0FA50F36B0 Q47709745-2F274D62-20DF-4C39-9952-467D05490EFC Q49367260-3F4A8599-D4AD-40CC-B8C1-B2F138EE84FB Q55177909-450F165A-21F4-4985-BEDB-33CEC8DA1429 Q58795617-4E628D23-3208-4F4D-9C59-D1C0535C0F3F

P2860

Thiazolidinediones as anti-cancer agents.

http://www.wikidata.org/entity/Q37010188

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Thiazolidinediones as anti-cancer agents.

@en

Thiazolidinediones as anti-cancer agents.

@nl

type

label

Thiazolidinediones as anti-cancer agents.

@en

Thiazolidinediones as anti-cancer agents.

@nl

prefLabel

Thiazolidinediones as anti-cancer agents.

@en

Thiazolidinediones as anti-cancer agents.

@nl

P1433

Q37010188-8DA1C5BF-BF94-4AE9-8172-D0FF9F7D12E9

P1476

Q37010188-7E230A47-A487-467D-B79E-141956FD10EB

P2093

Q37010188-3C569EE9-57E5-4217-ABF2-3F6FCD1224A2

Q37010188-90ADA7CA-D2DD-4247-A093-F3DB4E0DACE0

Q37010188-E4493428-F531-4BDA-91EC-A7C3607C0467

P2860

Q37010188-0065CBF1-F69A-4ED5-BD38-9AE2D702A4A0

Q37010188-057C5C4B-354B-4BCE-ABFC-A9E740492E12

Q37010188-08B97818-C76B-43B1-B0C8-5B7C8B3C04DE

Q37010188-09857230-350B-408A-AAE2-3A6277C745E6

Q37010188-105F7F84-BFB7-4D6F-86C6-6980612D0141

Q37010188-136D3040-CF4D-4A3B-88A5-3B93F9BFE1B0

Q37010188-13C811AE-5523-44AD-BFBE-759E68B3480E

Q37010188-1A04F4AB-84DB-4107-A537-8EC3526C4CDA

Q37010188-1A68258B-11AC-4CB7-BE93-A0922F722608

Q37010188-1BC97DF3-0CCD-490E-85CA-8FEFFCDE42EF

P304

Q37010188-F9BBEFA3-08C8-46B6-9C96-B26631B9E6FB

P31

Q37010188-371E5B0B-9081-4C8C-8B71-0B0905AB947B

P433

Q37010188-179F30E3-7727-4F01-BE9B-43B3D99C8FC7

P478

Q37010188-628E9B7A-8F28-4EB0-B69F-219320553658

P577

Q37010188-695FD23B-58E4-4C3E-8A70-6D3682ADFEBB

P698

Q37010188-64BF7072-A28F-4E88-A412-80C057988BF5

P932

Q37010188-EB83A3E1-4DEA-4695-ACBA-ABFE8B695123

P1433

P1476

Thiazolidinediones as anti-cancer agents.

@en

P2093

C Michael Hart

http://www.w3.org/2001/XMLSchema#string

Carmelo Blanquicett

http://www.w3.org/2001/XMLSchema#string

Jesse Roman

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells

The organization, promoter analysis, and expression of the human PPARgamma gene

Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.

Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System

Medical significance of peroxisome proliferator-activated receptors.

Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.

Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.

Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

P304

25-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

A

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19079765

http://www.w3.org/2001/XMLSchema#string

P932

2600565

http://www.w3.org/2001/XMLSchema#string